Kopin (KOPN) 10-Q 12 Nov 24 2024 Q3 Quarterly report Financial data

Cover

Cover - $ / shares	9 Months Ended
	Sep. 28, 2024	Nov. 12, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 28, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-30
Entity File Number	0-19882
Entity Registrant Name	KOPIN CORPORATION
Entity Central Index Key	0000771266
Entity Tax Identification Number	04-2833935
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	125 North Drive
Entity Address, City or Town	Westborough
Entity Address, State or Province	MA
Entity Address, Postal Zip Code	01581-3335
City Area Code	(508)
Local Phone Number	870-5959
Title of 12(b) Security	Common Stock, par value $0.01
Trading Symbol	KOPN
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		158,800,600
Entity Listing, Par Value Per Share	$ 0.01

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Current assets:
Cash and cash equivalents	$ 14,530,593	$ 5,710,685
Restricted cash	1,050,000	500,000
Marketable securities, at fair value	21,712,243	11,692,000
Accounts receivable, net of allowance of $1,015,000 in 2024 and $1,025,000 in 2023	9,233,935	9,706,036
Contract assets and unbilled receivables	8,274,538	3,409,809
Inventory	6,555,359	7,601,806
Prepaid taxes	84,885	85,572
Prepaid expenses and other current assets	1,561,710	1,124,635
Total current assets	63,003,263	39,830,543
Property, plant and equipment, net	2,016,452	2,163,417
Operating lease right-of-use assets	2,305,433	2,504,909
Other assets	124,925	124,925
Equity investments	3,129,434	4,688,522
Total assets	70,579,507	49,312,316
Current liabilities:
Accounts payable	4,385,635	4,947,338
Accrued payroll and expenses	1,724,776	1,701,506
Accrued warranty	2,675,000	2,160,000
Contract liabilities and billings in excess of revenues earned	268,468	916,826
Operating lease liabilities	653,546	651,503
Accrued post-retirement benefits	227,500	790,000
Other accrued liabilities	1,971,681	1,702,681
Customer deposits	102,481	408,156
Deferred tax liabilities	470,884	470,884
Accrued legal expenses	6,666,717	2,129,421
Accrued litigation damages	24,800,000
Total current liabilities	43,946,688	15,878,315
Noncurrent contract liabilities and asset retirement obligations	372,903	278,112
Operating lease liabilities, net of current portion	1,634,390	1,832,982
Accrued post-retirement benefits, net of current portion	279,996	319,996
Other long-term obligations, net of current portion	1,619,016	1,494,016
Total liabilities	47,852,993	19,803,421
Commitments and contingencies (Note 14)
Stockholders’ equity:
Preferred stock, par value $.01 per share: authorized, 3,000 shares; none issued
Common stock, par value $.01 per share: authorized, 200,000,000 shares in 2024 and 150,000,000 in 2023; issued 158,769,894 shares in 2024 and 114,253,818 shares in 2023; outstanding 153,182,916 in 2024 and 112,251,416 in 2023, respectively	1,532,589	1,123,220
Additional paid-in capital	420,066,150	385,411,542
Treasury stock (76,064 shares in 2024 and 70,635 in 2023, at cost)	(103,181)	(103,127)
Accumulated other comprehensive income	1,316,545	1,232,294
Accumulated deficit	(400,085,589)	(358,155,034)
Total stockholders’ equity	22,726,514	29,508,895
Total liabilities and stockholders’ equity	$ 70,579,507	$ 49,312,316

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 1,015,000	$ 1,025,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	3,000	3,000
Preferred stock, shares issued	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	200,000,000	150,000,000
Common stock, shares issued	158,769,894	114,253,818
Common stock, shares outstanding	153,182,916	112,251,416
Treasury stock, shares	76,064	70,635

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Revenues:
Total revenues	$ 13,319,608	$ 10,598,497	$ 35,688,672	$ 31,816,544
Expenses:
Cost of product revenues	8,316,904	5,437,953	25,543,806	17,759,117
Research and development	2,596,649	3,089,935	6,537,065	8,534,411
Selling, general and administration	5,206,880	4,798,598	19,706,613	15,912,848
Litigation damages			24,800,000
Total expenses	16,120,433	13,326,486	76,587,484	42,206,376
Loss from operations	(2,800,825)	(2,727,989)	(40,898,812)	(10,389,832)
Other (expense) income
Interest income	220,017	299,506	619,534	623,971
Other income	6,176	31,608	25,000	104,403
Loss on impairment of investments, net	(903,609)		(1,637,895)	(3,327,347)
Foreign currency transaction gains (losses)	142,899	(14,438)	86,618	(153,442)
Total other (expense) income, net	(534,517)	316,676	(906,743)	(2,752,415)
Loss before provision for income taxes	(3,335,342)	(2,411,313)	(41,805,555)	(13,142,247)
Tax provision	(125,000)	(39,000)	(125,000)	(117,000)
Net loss	$ (3,460,342)	$ (2,450,313)	$ (41,930,555)	$ (13,259,247)
Net loss per share
Basic	$ (0.03)	$ (0.02)	$ (0.34)	$ (0.12)
Diluted	$ (0.03)	$ (0.02)	$ (0.34)	$ (0.12)
Weighted average number of common shares outstanding
Basic	124,318,056	110,360,814	121,944,597	108,436,146
Diluted	124,318,056	110,360,814	121,944,597	108,436,146
Net Product Revenues [Member]
Revenues:
Total revenues	$ 10,922,470	$ 5,506,193	$ 31,001,866	$ 19,172,302
Research and Development Revenues [Member]
Revenues:
Total revenues	2,268,072	4,956,386	4,338,366	11,737,062
Other Revenues [Member]
Revenues:
Total revenues	$ 129,066	$ 135,918	$ 348,440	$ 907,180

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Income Statement [Abstract]
Net loss	$ (3,460,342)	$ (2,450,313)	$ (41,930,555)	$ (13,259,247)
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments	(25,035)	(10,229)	(24,795)	31,955
Unrealized holding gain (loss) on marketable securities	18,236	(54,175)	109,046	(72,382)
Other comprehensive (loss) income, net of tax	(6,799)	(64,404)	84,251	(40,427)
Comprehensive loss	$ (3,467,141)	$ (2,514,717)	$ (41,846,304)	$ (13,299,674)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Treasury Stock, Common [Member]	AOCI Attributable to Parent [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Parent [Member]	Total
Balance at Dec. 31, 2022	$ 929,540	$ 360,567,631	$ (103,127)	$ 1,176,068	$ (338,406,815)	$ (172,682)	$ 24,163,297	$ 23,990,615
Balance, shares at Dec. 31, 2022	92,954,159
Vesting of restricted stock	$ 175	(175)
Vesting of restricted stock, shares	17,500
Stock-based compensation expense		194,190					194,190	194,190
Other comprehensive loss				6,227			6,227	6,227
Issuance of common stock, net of costs	$ 170,000	21,165,000					21,335,000	21,335,000
Issuance of common stock, net of costs, shares	17,000,000
Net loss					(2,628,555)		(2,628,555)	(2,628,555)
Acquisition of noncontrolling interest		(172,682)				172,682	(172,682)
Balance at Apr. 01, 2023	$ 1,099,715	381,753,964	(103,127)	1,182,295	(341,035,370)		42,897,477	42,897,477
Balance, shares at Apr. 01, 2023	109,971,659
Balance at Dec. 31, 2022	$ 929,540	360,567,631	(103,127)	1,176,068	(338,406,815)	(172,682)	24,163,297	23,990,615
Balance, shares at Dec. 31, 2022	92,954,159
Other comprehensive loss								(40,427)
Net loss								(13,259,247)
Balance at Sep. 30, 2023	$ 1,104,668	383,898,603	(103,127)	1,135,641	(351,666,062)		34,369,723	34,369,723
Balance, shares at Sep. 30, 2023	110,466,852
Balance at Apr. 01, 2023	$ 1,099,715	381,753,964	(103,127)	1,182,295	(341,035,370)		42,897,477	42,897,477
Balance, shares at Apr. 01, 2023	109,971,659
Vesting of restricted stock	$ 4,050	(4,050)
Vesting of restricted stock, shares	404,966
Stock-based compensation expense		1,191,257					1,191,257	1,191,257
Other comprehensive loss				17,750			17,750	17,750
Net loss					(8,180,379)		(8,180,379)	(8,180,379)
Balance at Jul. 01, 2023	$ 1,103,765	382,941,171	(103,127)	1,200,045	(349,215,749)		35,926,105	35,926,105
Balance, shares at Jul. 01, 2023	110,376,625
Vesting of restricted stock	$ 903	(903)
Vesting of restricted stock, shares	90,227
Stock-based compensation expense		958,335					958,335	958,335
Other comprehensive loss				(64,404)			(64,404)	(64,404)
Net loss					(2,450,313)		(2,450,313)	(2,450,313)
Balance at Sep. 30, 2023	$ 1,104,668	383,898,603	(103,127)	1,135,641	(351,666,062)		34,369,723	34,369,723
Balance, shares at Sep. 30, 2023	110,466,852
Balance at Dec. 30, 2023	$ 1,123,220	385,411,542	(103,127)	1,232,294	(358,155,034)		29,508,895
Balance, shares at Dec. 30, 2023	112,322,051
Vesting of restricted stock	$ 200	(200)
Vesting of restricted stock, shares	20,064
Stock-based compensation expense		734,928					734,928
Other comprehensive loss				1,836			1,836
Issuance of common stock, net of costs	$ 30,800	7,211,781					7,242,581
Issuance of common stock, net of costs, shares	3,080,000
Net loss					(32,548,215)		(32,548,215)
Balance at Mar. 30, 2024	$ 1,154,220	393,358,051	(103,127)	1,234,130	(390,703,249)		4,940,025
Balance, shares at Mar. 30, 2024	115,422,115
Balance at Dec. 30, 2023	$ 1,123,220	385,411,542	(103,127)	1,232,294	(358,155,034)		29,508,895
Balance, shares at Dec. 30, 2023	112,322,051
Other comprehensive loss								84,251
Net loss								(41,930,555)
Balance at Sep. 28, 2024	$ 1,532,589	420,066,150	(103,181)	1,316,545	(400,085,589)		22,726,514
Balance, shares at Sep. 28, 2024	153,258,980
Balance at Mar. 30, 2024	$ 1,154,220	393,358,051	(103,127)	1,234,130	(390,703,249)		4,940,025
Balance, shares at Mar. 30, 2024	115,422,115
Vesting of restricted stock	$ 2,264	(2,264)
Vesting of restricted stock, shares	226,395
Stock-based compensation expense		676,418					676,418
Other comprehensive loss				89,214			89,214
Net loss					(5,921,998)		(5,921,998)
Balance at Jun. 29, 2024	$ 1,156,484	394,032,205	(103,127)	1,323,344	(396,625,247)		(216,341)
Balance, shares at Jun. 29, 2024	115,648,510
Vesting of restricted stock	$ 11	(11)
Vesting of restricted stock, shares	1,070
Stock-based compensation expense		1,212,946					1,212,946
Other comprehensive loss				(6,799)			(6,799)	$ (6,799)
Issuance of common stock, net of costs	$ 376,094	24,821,010	(54)				25,197,050
Issuance of common stock, net of costs, shares	37,609,400
Net loss					(3,460,342)		(3,460,342)
Balance at Sep. 28, 2024	$ 1,532,589	$ 420,066,150	$ (103,181)	$ 1,316,545	$ (400,085,589)		$ 22,726,514
Balance, shares at Sep. 28, 2024	153,258,980

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Apr. 01, 2023	Sep. 28, 2024	Sep. 30, 2023	Dec. 30, 2023
Cash flows from operating activities:
Net loss	$ (2,450,313)	$ (2,628,555)	$ (41,930,555)	$ (13,259,247)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			470,627	498,188
Stock-based compensation			2,624,292	2,343,782
Income taxes			125,000	117,316
Foreign currency losses			(133,002)	27,478
Provision for credit losses			24,000	726,413
Noncash provision for excess inventory			1,502,468	292,405
Investment impairment			1,787,852	2,887,893
Loss on sale of property and plant				18,878
Changes in other non-cash items			514,321	194,890
Changes in assets and liabilities:
Accounts receivable			1,031,331	(2,137,460)
Contract assets and unbilled receivables			(5,074,336)	(1,651,437)
Inventory			(390,427)	(2,944,672)
Prepaid expenses, other current assets and other assets			(426,901)	(461,365)
Accounts payable and accrued expenses			3,106,567	1,799,444
Contract liabilities and billings in excess of revenue earned			(671,790)	(244,188)
Accrued litigation damages			24,800,000
Net cash used in operating activities			(12,640,553)	(11,791,682)	$ (15,300,000)
Cash flows from investing activities:
Capital expenditures			(320,873)	(478,282)
Purchases of marketable securities			(16,875,308)	(17,624,779)
Proceeds from sale of marketable securities			6,915,102	10,374,593
Other assets			(152,971)	14,656
Net cash used in investing activities			(10,434,050)	(7,713,812)
Cash flows from financing activities:
Issuance of common stock, net of costs			7,242,581
Issuance of common stock and pre-funded warrants, net of costs			25,197,050	21,335,000
Net cash provided by financing activities			32,439,631	21,335,000
Effect of exchange rate changes on cash			4,880	11,291
Net increase in cash, cash equivalents and restricted cash			9,369,908	1,840,797
Cash, cash equivalents and restricted cash:
Beginning of period		$ 8,258,878	6,210,685	8,258,878	8,258,878
End of period	$ 10,099,675		$ 15,580,593	$ 10,099,675	$ 6,210,685

BASIS OF PRESENTATION

BASIS OF PRESENTATION	9 Months Ended
	Sep. 28, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION The condensed consolidated financial statements of Kopin Corporation as of September 28, 2024 and for the three and nine month periods ended September 28, 2024 and September 30, 2023 are unaudited and include all adjustments, including normal recurring adjustments, that, in the opinion of management, are necessary to present fairly the results of operations for the periods then ended. These condensed consolidated financial statements should be read in conjunction with the Company’s financial statements and notes thereto, included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023. The results of the Company’s operations for any interim period are not necessarily indicative of the results of the Company’s operations for any other interim period or for a full fiscal year. As used in this report, the terms “we”, “us”, “our”, “Kopin” and the “Company” mean Kopin Corporation and its subsidiaries, unless the context indicates another meaning. The condensed consolidated financial statements for the three and nine month periods ended September 28, 2024 and September 30, 2023 include the accounts of Kopin Corporation and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated. Going Concern The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company incurred a net loss of $ 19.7 million and net cash outflows from operations of $ 15.3 million for the fiscal year ended 2023. The Company incurred a net loss of $ 41.9 million for the nine months ended September 28, 2024 and net cash outflows from operations of $ 12.6 million. This net loss of $ 41.9 million includes an estimated $ 24.8 million of possible damages related to a jury verdict which is explained below. In addition, the Company has experienced a significant decline in its cash and cash equivalents and marketable securities over the last several years, which was primarily a result of funding operating losses. As described in Note 14 Litigation, on April 22, 2024, a jury verdict was entered against the Company awarding approximately $ 5.1 million in damages as well as recommending $ 19.7 million in disgorgement and exemplary damages. On May 22, 2024, the Company filed its Motion for Judgment as a Matter of Law or in the alternative for a New Trial, as well as two submissions arguing that the disgorgement and exemplary damages should not be awarded. That same day, BlueRadios filed motions seeking a permanent injunction prohibiting Kopin from selling any products that incorporate BlueRadios’ trade secrets, over $ 10 million in pre-judgment interest, and over $ 10 million in attorneys’ fees and costs. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after briefing on the issues. Final briefings on the motions were made by the parties on October 29, 2024. The Company is also considering the appeal of any award in a final judgment. The Company had $ 37.3 million of cash and cash equivalents, restricted cash, and marketable securities at September 28, 2024. The Company has historical and current negative cash flow from operations and limited liquidity resources. The Company’s current strategy is to continue to invest in its business and raise additional capital through financing activities that may include public offerings and private placements of its common stock, preferred stock offerings, collaborations and licensing arrangements and issuances of debt and convertible debt instruments. Until such time that additional capital can be raised, the Company plans to strategically manage its uncommitted spending, execute its priorities and implement cost saving measures to reduce research and development and general and administrative expenditures which could include minimizing staff costs. The Company may also sell assets and look at other strategic alternatives. There are inherent uncertainties associated with fundraising activities and activities to manage our uncommitted spending and the successful execution of these activities may not be within the Company’s control. There are no assurances that such additional funding will be obtained and that the Company will succeed in its future operations. If the Company is unable to achieve positive cash flows and profitability in the foreseeable future, cannot successfully raise additional capital and implement its strategic plan, or the recommended disgorgement and exemplary damages are not significantly reduced or eliminated in the final order, the Company’s liquidity, financial condition and business prospects will be materially and adversely affected. There is substantial doubt about the Company’s ability to continue as a going concern.

ACCOUNTING STANDARDS

ACCOUNTING STANDARDS	9 Months Ended
	Sep. 28, 2024
Accounting Policies [Abstract]
ACCOUNTING STANDARDS	2. ACCOUNTING STANDARDS In December 2023, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) Number 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”). ASU 2023-09 requires more disaggregated income tax disclosures, including additional information in the rate reconciliation and additional disclosures about income taxes paid. ASU 2023-09 will become effective for the Company for the fiscal year ending December 27, 2025. Early adoption is permitted, and guidance should be applied prospectively, with an option to apply guidance retrospectively. The Company is currently evaluating the impact of the adoption of ASU 2023-09 on its condensed consolidated financial statements. In November 2023, the FASB issued ASU Number 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures” (“ASU 2023-07”). ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker(s) that are included within each reported measure of segment profit or loss. The guidance also expands disclosure requirements for interim periods, as well as requires disclosure of other segment items, including the title and position of the entity’s chief operations decision maker(s). ASU 2023-07 will become effective for the Company for the fiscal year ending December 28, 2024, and for interim periods starting in the Company’s first quarter of 2025. Early adoption is permitted, and guidance is required to be applied retrospectively. The Company is currently evaluating the impact of the adoption of ASU 2023-07 on its condensed consolidated financial statements.

CASH AND CASH EQUIVALENTS, REST

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE SECURITIES	9 Months Ended
	Sep. 28, 2024
Cash and Cash Equivalents [Abstract]
CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE SECURITIES	3. CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE SECURITIES The Company considers all highly liquid, short-term debt instruments with original maturities of three months or less to be cash equivalents. Restricted cash of approximately $ 1.1 Marketable securities consist primarily of commercial paper, medium-term corporate notes, and U.S. Government and agency-backed securities. The Company classifies these marketable securities as available-for-sale at fair value in “Marketable securities, at fair value.” The Company records the amortization of premiums and accretion of discounts on marketable securities in the results of operations. The Company uses the specific identification method as a basis for determining cost and calculating realized gains and losses with respect to marketable securities. The gross gains and losses realized related to sales and maturities of marketable securities were not material during the three and nine months ended September 28, 2024 and September 30, 2023. Investments in available-for-sale marketable securities were as follows at September 28, 2024 and December 30, 2023: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Losses Fair Value 2024 2023 2024 2023 2024 2023 U.S. Government and agency-backed securities $ 17,256,314 $ 4,500,030 $ (1,609 ) $ (25,655 ) $ 17,254,705 $ 4,474,375 Corporate debt 4,954,096 7,750,174 3,442 (32,549 ) 4,957,538 7,717,625 Total $ 22,210,410 $ 12,250,204 $ 1,833 $ (58,204 ) $ 22,212,243 $ 12,192,000 The contractual maturity of the Company’s marketable securities was as follows at September 28, 2024: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One to Total U.S. Government and agency-backed securities $ 16,758,720 $ 495,985 $ 17,254,705 Corporate debt 4,957,538 — 4,957,538 Total $ 21,716,258 $ 495,985 $ 22,212,243

FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS	9 Months Ended
	Sep. 28, 2024
Fair Value Disclosures [Abstract]
FAIR VALUE MEASUREMENTS	4. FAIR VALUE MEASUREMENTS Financial instruments are categorized as Level 1, Level 2 or Level 3 based upon the method by which their fair value is computed. An investment is categorized as Level 1 when its fair value is based on unadjusted quoted prices in active markets for identical assets that the Company has the ability to access at the measurement date. An investment is categorized as Level 2 if its fair market value is based on quoted market prices for similar assets in active markets, quoted prices for identical or similar assets in markets that are not active, based on observable inputs such as interest rates, yield curves, or derived from or corroborated by observable market data by correlation or other means. An investment is categorized as Level 3 if its fair value is based on assumptions developed by the Company about what a market participant would use in pricing the assets. The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS Fair Value Measurement at September 28, 2024 Using: Total Level 1 Level 2 Level 3 Cash equivalents $ 12,279,360 $ 12,279,360 $ — $ — U.S. Government and agency-backed securities 17,254,705 15,758,720 1,495,985 — Corporate debt 4,957,538 4,957,538 — — Equity Investments 1,097,440 223,187 — 874,253 Financial instruments, owned, at fair value $ 35,589,043 $ 33,218,805 $ 1,495,985 $ 874,253 Fair Value Measurement at December 30, 2023 Using: Total Level 1 Level 2 Level 3 Cash equivalents $ 5,079,605 $ 5,079,605 $ — $ — U.S. Government and agency-backed securities 4,474,375 — 4,474,375 — Corporate debt 7,717,625 7,717,625 — — Equity Investments 4,688,522 174,178 — 4,514,344 Financial instruments, owned, at fair value $ 21,960,127 $ 12,971,408 $ 4,474,375 $ 4,514,344 The carrying amounts of cash and cash equivalents, accounts receivable, accounts payable and accrued liabilities approximate fair value because of their short-term nature. If accrued liabilities were carried at fair value, these would be classified as Level 2 in the fair value hierarchy. Marketable Securities Corporate debt consists of floating rate notes with a maturity that may be over multiple years but has interest rates that are reset every three months. US government and agency-backed securities consist of high-quality U.S. Government and government-backed (e.g., Fannie Mae, FDIC guaranteed bonds and certificates of deposit) securities. The Company validates the fair market values of the financial instruments above by using discounted cash flow models, obtaining independent pricing of the securities or through the use of a model that incorporates the three-month interest rate, the credit default swap rate of the issuer and the bid and ask price spread of the same or similar investments which are traded on several markets. Equity Investments The Company has an investment in RealWear Inc. (RealWear) which had been valued at $ 5.2 0.4 3.1 2.5 0.7 1.1 0.7 2.8 The equity investments categorized as Level 1 at September 28, 2024 were the Company’s equity investments in publicly traded companies that met the categorization requirements for Level 1 classification. The equity investments that were not remeasured to fair value and therefore did not meet the Level 1, Level 2 or Level 3 classification requirements had a value of $ 2.0 As of September 28, 2024, the Level 3 equity investments include the Company’s investment in RealWear of $ 0.7

ACCOUNTS RECEIVABLE, NET

ACCOUNTS RECEIVABLE, NET	9 Months Ended
	Sep. 28, 2024
Receivables [Abstract]
ACCOUNTS RECEIVABLE, NET	5. ACCOUNTS RECEIVABLE, NET Accounts receivable consisted of the following: SCHEDULE OF ACCOUNTS RECEIVABLE September 28, 2024 December 30, 2023 Accounts receivable $ 10,248,935 $ 10,731,036 Less — allowance for credit losses (1,015,000 ) (1,025,000 ) Total $ 9,233,935 $ 9,706,036 Changes to the allowance for credit losses for the nine months ended September 28, 2024 were as follows: SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES Balance, December 30, 2023 $ 1,025,000 Additions 24,000 Write-offs (34,000 ) Balance, September 28, 2024 $ 1,015,000

INVENTORY

INVENTORY	9 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
INVENTORY	6. INVENTORY Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 28, 2024 and December 30, 2023: SCHEDULE OF INVENTORY September 28, 2024 December 30, 2023 Raw materials $ 3,990,155 $ 4,785,197 Work-in-process 1,728,166 2,018,421 Finished goods 837,038 798,188 Total $ 6,555,359 $ 7,601,806

NET LOSS PER SHARE

NET LOSS PER SHARE	9 Months Ended
	Sep. 28, 2024
Net loss per share
NET LOSS PER SHARE	7. NET LOSS PER SHARE Basic net loss per share is computed using the weighted-average number of shares of common stock outstanding during the period less any unvested restricted shares. Diluted net loss per share is calculated using weighted-average shares outstanding and contingently issuable shares, less weighted-average shares reacquired during the period. The net outstanding shares are adjusted for the dilutive effect of shares issuable upon the assumed conversion of the Company’s common stock equivalents, which consist of unvested restricted stock, and outstanding warrants. The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive: SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK Three Months Three Months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Non-vested restricted common stock 5,510,914 3,948,417 5,510,914 3,948,417

STOCKHOLDERS_ EQUITY AND STOCK-

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	9 Months Ended
	Sep. 28, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION	8. STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION Registered sale of equity securities On September 23, 2024, the Company sold 37,550,000 4,000,000 0.64 27.0 1.8 0.01 On September 30, 2024, the Company sold 2,405,000 1.5 During the three months ended March 30, 2024, the Company sold 3,080,000 7,466,755 2.42 0.2 On January 27, 2023, the Company sold 17,000,000 6,000,000 0.99 22.9 1.5 0.01 Non-Vested Restricted Common Stock The fair value of non-vested restricted common stock awards is generally the market value of the Company’s common stock on the date of grant. The non-vested restricted common stock awards require the employee to fulfill certain obligations, including remaining employed by the Company for one, two or four years (the vesting period) and in certain cases also require meeting either performance criteria or the Company’s stock achieving a certain price. For non-vested restricted common stock awards that solely require the recipient to remain employed with the Company, the stock compensation expense is amortized over the anticipated service period. For non-vested restricted common stock awards that require the achievement of performance criteria, the Company reviews the probability of achieving the performance goals on a periodic basis. If the Company determines that it is probable that the performance criteria will be achieved, the amount of compensation cost derived for the performance goal is amortized over the anticipated service period. If the performance criteria are not met, no compensation cost is recognized and any previously recognized compensation cost is reversed. The Company granted 4,226,320 3,296,051 1,137,970 99,279 343,631 695,060 Restricted stock activity for the nine month period ended September 28, 2024 was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Shares Weighted Balance, December 30, 2023 1,931,767 $ 1.65 Granted 4,226,320 1.30 Forfeited (399,644 ) 2.50 Vested (247,529 ) 2.00 Balance, September 28, 2024 5,510,914 1.30 Stock-Based Compensation The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 28, 2024 and September 30, 2023 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Three Months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cost of product revenues $ 368,312 $ 311,455 $ 857,236 $ 764,996 Research and development 308,792 214,320 569,701 553,488 Selling, general and administrative 535,842 432,560 1,197,355 1,025,298 Total $ 1,212,946 $ 958,335 $ 2,624,292 $ 2,343,782 Stock based compensation expense $ 1,212,946 $ 958,335 $ 2,624,292 $ 2,343,782 Unrecognized compensation expense for non-vested restricted common stock as of September 28, 2024 totaled $ 4.2 two years

ACCRUED WARRANTY

ACCRUED WARRANTY	9 Months Ended
	Sep. 28, 2024
Guarantees and Product Warranties [Abstract]
ACCRUED WARRANTY	9. ACCRUED WARRANTY The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty. SCHEDULE OF ACCRUED WARRANTY Balance, December 30, 2023 $ 2,160,000 Additions 700,000 Claims (185,000 ) Balance, September 28, 2024 $ 2,675,000 Extended Warranties Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months standard 12 to 18-month warranty. 0.1

INCOME TAXES

INCOME TAXES	9 Months Ended
	Sep. 28, 2024
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES The Company recorded a provision for income taxes of approximately $ 0.1 in the three and nine months ended September 28, 2024, respectively. The Company recorded a provision for income taxes of less than $ 0.1 0.1 122.7 million expiring 2024 through 2038 and $ 107.8 million that have an unlimited carryover period. The Company has recognized a full valuation allowance on its domestic and certain foreign net deferred tax assets due to the uncertainty of the realization of such assets. The Company recognizes both accrued interest and penalties related to its uncertain tax positions related to intercompany loan interest and potential transfer pricing exposure related to its foreign subsidiaries.

CONTRACT ASSETS AND LIABILITIES

CONTRACT ASSETS AND LIABILITIES	9 Months Ended
	Sep. 28, 2024
Contract Assets And Liabilities
CONTRACT ASSETS AND LIABILITIES	11. CONTRACT ASSETS AND LIABILITIES Contract assets include unbilled amounts typically resulting from sales under contracts when the cost-to-cost method of revenue recognition is utilized and revenue recognized from customer arrangements, including licensing, exceeds the amount billed to the customer, and right to payment is not just subject to the passage of time. Amounts may not exceed their net realizable value. Contract assets are generally classified as current. The Company classifies the noncurrent portion of contract assets under Other assets in its condensed consolidated balance sheets. Contract liabilities consist of advance payments and billings in excess of cost incurred and deferred revenue. Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 28, 2024 December 30, 2023 $ Change % Change Contract assets and unbilled receivables —current $ 8,274,538 $ 3,409,809 $ 4,864,729 143 % Contract liabilities and billings in excess of revenues earned (268,468 ) (916,826 ) 648,358 (71 )% Contract liabilities—noncurrent — (23,198 ) 23,198 (100 )% Net contract assets $ 8,006,070 $ 2,469,785 $ 5,536,285 224 % The $ 5.5 In the three and nine months ended September 28, 2024, the Company recognized revenue of less than $ 0.1 0.9 0.1 0.7 The Company did not recognize impairment losses on its contract assets in the three or nine months ended September 28, 2024 or September 30, 2023. Performance Obligations The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Point in time 11 % 24 % 16 % 27 % Over time 89 % 76 % 84 % 73 % Performance obligation percentage 89 % 76 % 84 % 73 % Remaining performance obligations represent the transaction price of orders for which work has not been performed and excludes unexercised contract options and potential orders under ordering-type contracts (e.g., indefinite-delivery, indefinite-quantity (“IDIQ”)). As of September 28, 2024, the aggregate amount of the transaction price allocated to remaining performance obligations was $ 25.4

LEASES

LEASES	9 Months Ended
	Sep. 28, 2024
Leases
LEASES	12. LEASES The Company enters into operating leases primarily for: real estate, including for manufacturing, engineering, research, administration and sales facilities, and information technology (“IT”) equipment. At September 28, 2024 and December 30, 2023, the Company did not have any finance leases. Approximately all of its future lease commitments, and related lease liability, relate to the Company’s real estate leases. Some of the Company’s leases include options to extend or terminate the lease. The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Operating lease cost $ 218,348 $ 216,119 $ 651,718 $ 648,545 At September 28, 2024, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2024 (excluding the nine months ended September 28, 2024) $ 212,013 2025 766,014 2026 732,610 2027 669,255 2028 201,333 Total future lease payments 2,581,225 Less imputed interest (293,289 ) Total $ 2,287,936 The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheet at September 28, 2024 were as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 28, 2024 Operating lease liabilities–current $ 653,546 Operating lease liabilities–noncurrent 1,634,390 Total lease liabilities $ 2,287,936 Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 28, 2024 September 30, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 649,276 $ 741,757 Other information related to leases was as follows: September 28, 2024 September 30, 2023 Weighted Average Discount Rate–Operating Leases 6.80 % 6.06 % Weighted Average Remaining Lease Term–Operating Leases (in years) 3.38 4.11

SEGMENTS AND DISAGGREGATION OF

SEGMENTS AND DISAGGREGATION OF REVENUE	9 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
SEGMENTS AND DISAGGREGATION OF REVENUE	13. SEGMENTS AND DISAGGREGATION OF REVENUE The Company continually monitors and reviews its segment reporting structure in accordance with authoritative guidance to determine if any changes have occurred that would affect its reportable segments. The Company reports under one segment, as its Chief Executive Officer, who is its chief operating decision maker (“CODM”), reviews results on a total company basis. Total long-lived assets by country at September 28, 2024 and December 30, 2023 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 28, 2024 December 30, 2023 United States $ 4,199 $ 4,424 United Kingdom 123 244 Total $ 4,322 $ 4,668 Long lived assets $ 4,322 $ 4,668 The Company disaggregates its revenue from contracts with customers by geographic location and by display application, as it believes this best depicts how the nature, amount, timing and uncertainty of its revenue and cash flows are affected by economic factors. During the three and nine months ended September 28, 2024 and September 30, 2023, the Company derived its sales from the following geographies: SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 (In thousands, except percentages) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 12,612 95 % $ 9,879 94 % $ 33,352 93 % $ 27,788 88 % Other Americas — — — — 5 — 5 — Total Americas 12,612 95 9,879 94 33,357 93 27,793 88 Asia - Pacific 382 3 363 3 1,632 5 2,956 9 Europe 326 2 356 3 700 2 1,068 3 Total Revenues $ 13,320 100 % $ 10,598 100 % $ 35,689 100 % $ 31,817 100 % During the three and nine months ended September 28, 2024 and September 30, 2023, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Nine months ended Nine months ended (In thousands) September 28, 2024 September 30, September 28, 2024 September 30, Defense $ 10,434 $ 4,996 $ 29,095 $ 16,482 Industrial 489 310 1,883 2,118 Consumer — 200 25 573 R&D 2,268 4,956 4,338 11,737 License and royalties 129 136 348 907 Total Revenues $ 13,320 $ 10,598 $ 35,689 $ 31,817

LITIGATION

LITIGATION	9 Months Ended
	Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
LITIGATION	14. LITIGATION The Company may engage in legal proceedings arising in the ordinary course of business. Claims, suits, investigations and proceedings are inherently uncertain and it is not possible to predict the ultimate outcome of such matters and our business, financial condition, results of operations or cash flows could be affected in any particular period. BlueRadios, Inc. v. Kopin Corporation, Civil Action No. 16-02052-JLK (D. Col.): On August 12, 2016, BlueRadios, Inc. (“BlueRadios”) filed a complaint in the U.S. District Court for the District of Colorado, alleging that the Company breached a contract between it and BlueRadios concerning a joint venture between the Company and BlueRadios to design, develop and commercialize micro-display products with embedded wireless technology referred to as “Golden-i,” breached the covenant of good faith and fair dealing associated with that contract, breached its fiduciary duty to BlueRadios, and misappropriated trade secrets owned by BlueRadios in violation of Colorado law (C.R.S. § 7-74-104(4)) and the Defend Trade Secrets Act (18 U.S.C. § 1836(b)(1)). BlueRadios further alleged that the Company was unjustly enriched by its alleged misconduct, BlueRadios is entitled to an accounting to determine the amount of profits obtained by the Company as a result of its alleged misconduct, and the inventorship on at least ten patents or patent applications owned by the Company need to be corrected to list BlueRadios’ employees as inventors and thereby list BlueRadios as co-assignees of the patents. BlueRadios seeks monetary, declaratory, and injunctive relief, including for alleged non-payment of engineering retainer fees. On October 11, 2016, the Company filed its Answer and Affirmative Defenses. The parties completed expert depositions on November 15, 2019. On December 2, 2019, the Company filed a Motion for Partial Summary Judgment requesting the Court dismiss counts 2-7 in their entirety and counts 1 and 8 in part. BlueRadios also filed a Motion for Partial Summary Judgment alleging it is the co-owner of U.S. Patent No. 8,909,296. Responses to the Motions for Partial Summary Judgment were filed on January 15, 2020, and replies were filed on February 19, 2020. On September 25, 2020, the Court denied BlueRadios’ Motion for Partial Summary Judgment. On August 3, 2022, the Court granted the Company’s Motion for Partial Summary Judgment by dismissing counts 3, 6, 7, the claim for punitive damages under count 2, and count 8 as it relates to patent applications and by denying the motion as it relates to counts 1, 4, and 5, and the remainder of counts 2 and 8. The Court also ordered discovery reopened for certain limited purposes. A trial date was set by the Court for January 22 to February 5, 2024 but then re-scheduled for March 20 to April 16. On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after post-trial briefing. 10 10 BlueRadios, Inc. v. Hamilton, Brook, Smith & Reynolds, P.C. 5.1 19.7

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 28, 2024
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	15. RELATED PARTY TRANSACTIONS The Company may from time to time enter into agreements with stockholders, affiliates and other companies engaged in certain aspects of the display, electronics, optical and software industries as part of its business strategy. In addition, the wearable computing product market is relatively new and there may be other technologies the Company needs to purchase from affiliates to enhance its product offering. On January 5, 2023, the Company entered into a Technology License Agreement and an Asset Purchase Agreement (the “LST Agreements”) with Lightning Silicon Technology, Inc. (“LST”). Pursuant to the LST Agreements, the Company issued a license to LST for certain technology associated with its Organic Light Emitting Technology, transferred in-process development contracts with two customers and accounts receivables that the Company had previously determined were not collectible. The technology license agreement provides for Kopin to transfer certain patents to LST if LST achieves certain milestones, however upon transfer Kopin will receive a license to the technology. To the extent LST makes improvements to the technology licensed from Kopin, Kopin will receive a license for these improvements for certain markets. Kopin is not obligated to provide any additional funding support to LST. As consideration for the transaction, the Company received 18,000,000 20.0 0 During the three and nine months ended September 28, 2024 and September 30, 2023, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three months ended September 28, 2024 September 30, 2023 Sales Purchases Sales Purchases RealWear, Inc. $ 94,854 — $ 135,918 $ — HMDmd, Inc. 76,918 — 349,420 — Vuzix Corp — 11,905 — — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 924 6,650 — 208,933 $ 205,984 6,650 $ 485,338 $ 208,933 Nine months ended September 28, 2024 September 30, 2023 Sales Purchases Sales Purchases RealWear, Inc. $ 311,994 10,550 $ 905,564 $ — HMDmd, Inc. 299,177 — 852,175 — Vuzix Corp — 11,905 — — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 3,158 170,850 — 416,988 $ 647,617 193,305 $ 1,757,739 $ 416,988 At September 28, 2024 and December 30, 2023, the Company had the following receivables from and payables to related parties: September 28, 2024 December 30, 2023 Receivables Payables Receivables Payables RealWear, Inc. $ 94,854 $ — $ 94,902 $ — HMDmd, Inc. 101,922 — 15,000 — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 41 — 35,013 97,600 $ 230,105 $ — $ 144,915 $ 97,600

CASH AND CASH EQUIVALENTS, RE_2

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE SECURITIES (Tables)	9 Months Ended
	Sep. 28, 2024
Cash and Cash Equivalents [Abstract]
SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES	Investments in available-for-sale marketable securities were as follows at September 28, 2024 and December 30, 2023: SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES Amortized Cost Unrealized Losses Fair Value 2024 2023 2024 2023 2024 2023 U.S. Government and agency-backed securities $ 17,256,314 $ 4,500,030 $ (1,609 ) $ (25,655 ) $ 17,254,705 $ 4,474,375 Corporate debt 4,954,096 7,750,174 3,442 (32,549 ) 4,957,538 7,717,625 Total $ 22,210,410 $ 12,250,204 $ 1,833 $ (58,204 ) $ 22,212,243 $ 12,192,000
SCHEDULE OF MARKETABLE DEBT SECURITIES	The contractual maturity of the Company’s marketable securities was as follows at September 28, 2024: SCHEDULE OF MARKETABLE DEBT SECURITIES Less than One to Total U.S. Government and agency-backed securities $ 16,758,720 $ 495,985 $ 17,254,705 Corporate debt 4,957,538 — 4,957,538 Total $ 21,716,258 $ 495,985 $ 22,212,243

FAIR VALUE MEASUREMENTS (Tables

FAIR VALUE MEASUREMENTS (Tables)	9 Months Ended
	Sep. 28, 2024
Fair Value Disclosures [Abstract]
SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS	The following table details the fair value measurements of the Company’s financial assets: SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS Fair Value Measurement at September 28, 2024 Using: Total Level 1 Level 2 Level 3 Cash equivalents $ 12,279,360 $ 12,279,360 $ — $ — U.S. Government and agency-backed securities 17,254,705 15,758,720 1,495,985 — Corporate debt 4,957,538 4,957,538 — — Equity Investments 1,097,440 223,187 — 874,253 Financial instruments, owned, at fair value $ 35,589,043 $ 33,218,805 $ 1,495,985 $ 874,253 Fair Value Measurement at December 30, 2023 Using: Total Level 1 Level 2 Level 3 Cash equivalents $ 5,079,605 $ 5,079,605 $ — $ — U.S. Government and agency-backed securities 4,474,375 — 4,474,375 — Corporate debt 7,717,625 7,717,625 — — Equity Investments 4,688,522 174,178 — 4,514,344 Financial instruments, owned, at fair value $ 21,960,127 $ 12,971,408 $ 4,474,375 $ 4,514,344

ACCOUNTS RECEIVABLE, NET (Table

ACCOUNTS RECEIVABLE, NET (Tables)	9 Months Ended
	Sep. 28, 2024
Receivables [Abstract]
SCHEDULE OF ACCOUNTS RECEIVABLE	Accounts receivable consisted of the following: SCHEDULE OF ACCOUNTS RECEIVABLE September 28, 2024 December 30, 2023 Accounts receivable $ 10,248,935 $ 10,731,036 Less — allowance for credit losses (1,015,000 ) (1,025,000 ) Total $ 9,233,935 $ 9,706,036
SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES	Changes to the allowance for credit losses for the nine months ended September 28, 2024 were as follows: SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES Balance, December 30, 2023 $ 1,025,000 Additions 24,000 Write-offs (34,000 ) Balance, September 28, 2024 $ 1,015,000

INVENTORY (Tables)

INVENTORY (Tables)	9 Months Ended
	Sep. 28, 2024
Inventory Disclosure [Abstract]
SCHEDULE OF INVENTORY	Inventories are stated at standard cost adjusted to approximate the lower of cost (first-in, first-out method) or net realizable value and consist of the following at September 28, 2024 and December 30, 2023: SCHEDULE OF INVENTORY September 28, 2024 December 30, 2023 Raw materials $ 3,990,155 $ 4,785,197 Work-in-process 1,728,166 2,018,421 Finished goods 837,038 798,188 Total $ 6,555,359 $ 7,601,806

NET LOSS PER SHARE (Tables)

NET LOSS PER SHARE (Tables)	9 Months Ended
	Sep. 28, 2024
Net loss per share
SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK	The following were not included in weighted-average common shares outstanding-diluted because they are anti-dilutive: SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK Three Months Three Months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Non-vested restricted common stock 5,510,914 3,948,417 5,510,914 3,948,417

STOCKHOLDERS_ EQUITY AND STOC_2

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)	9 Months Ended
	Sep. 28, 2024
Equity [Abstract]
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY	Restricted stock activity for the nine month period ended September 28, 2024 was as follows: SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY Shares Weighted Balance, December 30, 2023 1,931,767 $ 1.65 Granted 4,226,320 1.30 Forfeited (399,644 ) 2.50 Vested (247,529 ) 2.00 Balance, September 28, 2024 5,510,914 1.30
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE	The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 28, 2024 and September 30, 2023 (no tax benefits were recognized): SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE Three Months Three Months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Cost of product revenues $ 368,312 $ 311,455 $ 857,236 $ 764,996 Research and development 308,792 214,320 569,701 553,488 Selling, general and administrative 535,842 432,560 1,197,355 1,025,298 Total $ 1,212,946 $ 958,335 $ 2,624,292 $ 2,343,782 Stock based compensation expense $ 1,212,946 $ 958,335 $ 2,624,292 $ 2,343,782

ACCRUED WARRANTY (Tables)

ACCRUED WARRANTY (Tables)	9 Months Ended
	Sep. 28, 2024
Guarantees and Product Warranties [Abstract]
SCHEDULE OF ACCRUED WARRANTY	SCHEDULE OF ACCRUED WARRANTY Balance, December 30, 2023 $ 2,160,000 Additions 700,000 Claims (185,000 ) Balance, September 28, 2024 $ 2,675,000

CONTRACT ASSETS AND LIABILITI_2

CONTRACT ASSETS AND LIABILITIES (Tables)	9 Months Ended
	Sep. 28, 2024
Contract Assets And Liabilities
SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY	Net contract assets (liabilities) consisted of the following: SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY September 28, 2024 December 30, 2023 $ Change % Change Contract assets and unbilled receivables —current $ 8,274,538 $ 3,409,809 $ 4,864,729 143 % Contract liabilities and billings in excess of revenues earned (268,468 ) (916,826 ) 648,358 (71 )% Contract liabilities—noncurrent — (23,198 ) 23,198 (100 )% Net contract assets $ 8,006,070 $ 2,469,785 $ 5,536,285 224 %
SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION	The Company’s revenue recognition related to performance obligations that were satisfied at a point in time and over time were as follows: SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Point in time 11 % 24 % 16 % 27 % Over time 89 % 76 % 84 % 73 % Performance obligation percentage 89 % 76 % 84 % 73 %

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Sep. 28, 2024
Leases
SCHEDULE OF LEASE EXPENSE	The components of lease expense were as follows: SCHEDULE OF LEASE EXPENSE Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 Operating lease cost $ 218,348 $ 216,119 $ 651,718 $ 648,545
SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE	At September 28, 2024, the Company’s future lease payments under non-cancellable leases were as follows: SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE 2024 (excluding the nine months ended September 28, 2024) $ 212,013 2025 766,014 2026 732,610 2027 669,255 2028 201,333 Total future lease payments 2,581,225 Less imputed interest (293,289 ) Total $ 2,287,936
SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS	The Company’s lease liabilities recognized in the Company’s condensed consolidated balance sheet at September 28, 2024 were as follows: SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS September 28, 2024 Operating lease liabilities–current $ 653,546 Operating lease liabilities–noncurrent 1,634,390 Total lease liabilities $ 2,287,936
SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES	Supplemental cash flow information related to leases was as follows: SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES Nine months ended September 28, 2024 September 30, 2023 Cash paid for amounts included in the measurement of operating lease liabilities $ 649,276 $ 741,757 Other information related to leases was as follows: September 28, 2024 September 30, 2023 Weighted Average Discount Rate–Operating Leases 6.80 % 6.06 % Weighted Average Remaining Lease Term–Operating Leases (in years) 3.38 4.11

SEGMENTS AND DISAGGREGATION O_2

SEGMENTS AND DISAGGREGATION OF REVENUE (Tables)	9 Months Ended
	Sep. 28, 2024
Segment Reporting [Abstract]
SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS	Total long-lived assets by country at September 28, 2024 and December 30, 2023 were: SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS Total Long-lived Assets (in thousands) September 28, 2024 December 30, 2023 United States $ 4,199 $ 4,424 United Kingdom 123 244 Total $ 4,322 $ 4,668 Long lived assets $ 4,322 $ 4,668
SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE	During the three and nine months ended September 28, 2024 and September 30, 2023, the Company derived its sales from the following geographies: SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE Three months Three months Nine months Nine months September 28, 2024 September 30, 2023 September 28, 2024 September 30, 2023 (In thousands, except percentages) Revenue % of Total Revenue % of Total Revenue % of Total Revenue % of Total United States $ 12,612 95 % $ 9,879 94 % $ 33,352 93 % $ 27,788 88 % Other Americas — — — — 5 — 5 — Total Americas 12,612 95 9,879 94 33,357 93 27,793 88 Asia - Pacific 382 3 363 3 1,632 5 2,956 9 Europe 326 2 356 3 700 2 1,068 3 Total Revenues $ 13,320 100 % $ 10,598 100 % $ 35,689 100 % $ 31,817 100 %
SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT	During the three and nine months ended September 28, 2024 and September 30, 2023, the Company derived its sales from the following display applications: SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT Three months ended Three months ended Nine months ended Nine months ended (In thousands) September 28, 2024 September 30, September 28, 2024 September 30, Defense $ 10,434 $ 4,996 $ 29,095 $ 16,482 Industrial 489 310 1,883 2,118 Consumer — 200 25 573 R&D 2,268 4,956 4,338 11,737 License and royalties 129 136 348 907 Total Revenues $ 13,320 $ 10,598 $ 35,689 $ 31,817

RELATED PARTY TRANSACTIONS (Tab

RELATED PARTY TRANSACTIONS (Tables)	9 Months Ended
	Sep. 28, 2024
Related Party Transactions [Abstract]
SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES	During the three and nine months ended September 28, 2024 and September 30, 2023, the Company had the following transactions with related parties: SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES Three months ended September 28, 2024 September 30, 2023 Sales Purchases Sales Purchases RealWear, Inc. $ 94,854 — $ 135,918 $ — HMDmd, Inc. 76,918 — 349,420 — Vuzix Corp — 11,905 — — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 924 6,650 — 208,933 $ 205,984 6,650 $ 485,338 $ 208,933 Nine months ended September 28, 2024 September 30, 2023 Sales Purchases Sales Purchases RealWear, Inc. $ 311,994 10,550 $ 905,564 $ — HMDmd, Inc. 299,177 — 852,175 — Vuzix Corp — 11,905 — — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 3,158 170,850 — 416,988 $ 647,617 193,305 $ 1,757,739 $ 416,988 At September 28, 2024 and December 30, 2023, the Company had the following receivables from and payables to related parties: September 28, 2024 December 30, 2023 Receivables Payables Receivables Payables RealWear, Inc. $ 94,854 $ — $ 94,902 $ — HMDmd, Inc. 101,922 — 15,000 — Solos Technology 33,288 — — — Lightning Silicon Technology, Inc. 41 — 35,013 97,600 $ 230,105 $ — $ 144,915 $ 97,600

BASIS OF PRESENTATION (Details

BASIS OF PRESENTATION (Details Narrative) - USD ($)			3 Months Ended		9 Months Ended		12 Months Ended
	May 22, 2024	Apr. 22, 2024	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Dec. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Net Income (Loss) Attributable to Parent			$ 3,460,342	$ 2,450,313	$ 41,930,555	$ 13,259,247	$ 19,700,000
Net Cash Provided by (Used in) Operating Activities					12,640,553	$ 11,791,682	$ 15,300,000
[custom:EstimatedPossibleDamagesAmount]					24,800,000
Litigation Settlement, Loss		$ 5,100,000
Payments for Legal Settlements		$ 19,700,000
Prepaid Interest	$ 10,000,000
Legal Fees	$ 10,000,000
Cash, Cash Equivalents, and Short-Term Investments			$ 37,300,000		$ 37,300,000

SCHEDULE OF AVAILABLE-FOR-SALE

SCHEDULE OF AVAILABLE-FOR-SALE MARKETABLE DEBT SECURITIES (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	$ 22,210,410	$ 12,250,204
Unrealized Losses	1,833	(58,204)
Fair Value	22,212,243	12,192,000
U.S. Government and Agency Backed Securities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	17,256,314	4,500,030
Unrealized Losses	(1,609)	(25,655)
Fair Value	17,254,705	4,474,375
Corporate Debt [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Amortized Cost	4,954,096	7,750,174
Unrealized Losses	3,442	(32,549)
Fair Value	$ 4,957,538	$ 7,717,625

SCHEDULE OF MARKETABLE DEBT SEC

SCHEDULE OF MARKETABLE DEBT SECURITIES (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	$ 21,716,258
One to Five years	495,985
Marketable debt securities	22,212,243	$ 12,192,000
US Government Agencies Debt Securities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	16,758,720
One to Five years	495,985
Marketable debt securities	17,254,705
Corporate Debt Securities [Member]
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]
Less than One year	4,957,538
One to Five years
Marketable debt securities	$ 4,957,538

CASH AND CASH EQUIVALENTS, RE_3

CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND MARKETABLE SECURITIES (Details Narrative) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Cash and Cash Equivalents [Abstract]
Restricted cash	$ 1,050,000	$ 500,000

SCHEDULE OF FAIR VALUE MEASUREM

SCHEDULE OF FAIR VALUE MEASUREMENTS OF FINANCIAL ASSETS (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	$ 35,589,043	$ 21,960,127
Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	33,218,805	12,971,408
Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	1,495,985	4,474,375
Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	874,253	4,514,344
Cash and Cash Equivalents [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	12,279,360	5,079,605
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	12,279,360	5,079,605
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Cash and Cash Equivalents [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
U.S. Government and Agency Backed Securities [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	17,254,705	4,474,375
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	15,758,720
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	1,495,985	4,474,375
U.S. Government and Agency Backed Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Corporate Debt Securities [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,957,538	7,717,625
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	4,957,538	7,717,625
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Corporate Debt Securities [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Investments [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	1,097,440	4,688,522
Equity Investments [Member] | Fair Value, Inputs, Level 1 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	223,187	174,178
Equity Investments [Member] | Fair Value, Inputs, Level 2 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value
Equity Investments [Member] | Fair Value, Inputs, Level 3 [Member]
Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]
Financial instruments, owned, at fair value	$ 874,253	$ 4,514,344

FAIR VALUE MEASUREMENTS (Detail

FAIR VALUE MEASUREMENTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Jun. 29, 2024	Jul. 01, 2023	Sep. 28, 2024	Dec. 30, 2023
Investments			$ 5,200,000
Payments for royalties		$ 400,000
Asset impairment charges	$ 700,000	3,100,000	1,100,000
Increase (decrease) in receivable for investment sold	$ 700,000	$ 2,500,000
Equity investments			2,000,000
Equity method investments			3,129,434	$ 4,688,522
RealWear, Inc. [Member]
Equity method investments			$ 700,000
RealWear, Inc. [Member]
Equity method investment, ownership percentage			2.80%

SCHEDULE OF ACCOUNTS RECEIVABLE

SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Receivables [Abstract]
Accounts receivable	$ 10,248,935	$ 10,731,036
Less — allowance for credit losses	(1,015,000)	(1,025,000)
Total	$ 9,233,935	$ 9,706,036

SCHEDULE OF CHANGE IN ALLOWANCE

SCHEDULE OF CHANGE IN ALLOWANCE FOR CREDIT LOSSES (Details)	9 Months Ended
	Sep. 28, 2024 USD ($)
Receivables [Abstract]
Balance, December 30, 2023	$ 1,025,000
Additions	24,000
Write-offs	(34,000)
Balance, September 28, 2024	$ 1,015,000

SCHEDULE OF INVENTORY (Details)

SCHEDULE OF INVENTORY (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 3,990,155	$ 4,785,197
Work-in-process	1,728,166	2,018,421
Finished goods	837,038	798,188
Total	$ 6,555,359	$ 7,601,806

SCHEDULE OF NON-VESTED RESTRICT

SCHEDULE OF NON-VESTED RESTRICTED COMMON STOCK (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Net loss per share
Non-vested restricted common stock	5,510,914	3,948,417	5,510,914	3,948,417

SCHEDULE OF NON-VESTED RESTRI_2

SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY (Details)	9 Months Ended
	Sep. 28, 2024 $ / shares shares
Equity [Abstract]
Number of Shares, Outstanding | shares	1,931,767
Weighted Average Grant Fair Value, Outstanding | $ / shares	$ 1.65
Number of Shares, Granted | shares	4,226,320
Weighted Average Grant Fair Value, Granted | $ / shares	$ 1.30
Number of Shares, Forfeited | shares	(399,644)
Weighted Average Grant Fair Value, Forfeited | $ / shares	$ 2.50
Number of Shares, Vested | shares	(247,529)
Weighted Average Grant Fair Value, Vested | $ / shares	$ 2
Number of Shares, Outstanding | shares	5,510,914
Weighted Average Grant Fair Value, Outstanding | $ / shares	$ 1.30

SCHEDULE OF STOCK-BASED COMPENS

SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Jul. 01, 2023	Sep. 28, 2024	Sep. 30, 2023
Stock based compensation expense	$ 1,212,946	$ 958,335	$ 2,624,292	$ 2,343,782
Cost of Product Revenues [Member]
Stock based compensation expense	368,312	311,455	857,236	764,996
Research and Development [Member]
Stock based compensation expense	308,792	214,320	569,701	553,488
Selling General and Administrative [Member]
Stock based compensation expense	$ 535,842	$ 432,560	$ 1,197,355	$ 1,025,298

STOCKHOLDERS_ EQUITY AND STOC_3

STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Details Narrative) - USD ($)				3 Months Ended	9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 23, 2024	Jan. 27, 2023	Mar. 30, 2024	Sep. 28, 2024	Sep. 30, 2023	Dec. 28, 2024
Class of Warrant or Right [Line Items]
Number of registered common stock sold		37,550,000	17,000,000	3,080,000
Gross proceeds from registered sale equity securities				$ 7,466,755
Share price				$ 2.42
Restricted stock granted					4,226,320
Restricted stock, vested					247,529
Restricted stock forfeited					399,644
Unrecognized compensation expense					$ 4,200,000
Weighted average period, unrecognized					2 years
Successful Achievement of Milestones [Member] | Forecast [Member]
Class of Warrant or Right [Line Items]
Restricted stock, vested							1,137,970
Achievement of Milestones [Member]
Class of Warrant or Right [Line Items]
Restricted stock earned					99,279
Failure to Meet of Milestones [Member]
Class of Warrant or Right [Line Items]
Restricted stock forfeited					343,631
Achieving Milestones [Member] | Forecast [Member]
Class of Warrant or Right [Line Items]
Restricted stock earned							695,060
Restricted Stock Units (RSUs) [Member]
Class of Warrant or Right [Line Items]
Restricted stock granted					4,226,320	3,296,051
At-The-Market Equity Offering Sales Agreement [Member]
Class of Warrant or Right [Line Items]
Payment of expenses				$ 200,000
Subsequent Event [Member]
Class of Warrant or Right [Line Items]
Number of registered common stock sold	2,405,000
Proceeds from issuance of warrants	$ 1,500,000
Prefunded Warrants [Member]
Class of Warrant or Right [Line Items]
Pre-funded warrants issued to purchase common stock		4,000,000	6,000,000
Offering price per share		$ 0.64	$ 0.99
Proceeds from issuance of warrants		$ 27,000,000	$ 22,900,000
Underwriting discounts and offering expenses		$ 1,800,000	$ 1,500,000
Exercise price of warrants		$ 0.01	$ 0.01

SCHEDULE OF ACCRUED WARRANTY (D

SCHEDULE OF ACCRUED WARRANTY (Details)	9 Months Ended
	Sep. 28, 2024 USD ($)
Guarantees and Product Warranties [Abstract]
Balance, December 30, 2023	$ 2,160,000
Additions	700,000
Claims	(185,000)
Balance, September 28, 2024	$ 2,675,000

ACCRUED WARRANTY (Details Narra

ACCRUED WARRANTY (Details Narrative) $ in Millions	9 Months Ended
	Sep. 28, 2024 USD ($)
Product Information [Line Items]
Extended product warranty description	The Company typically warrants its products against defect for 12 to 18 months, however, for certain products a customer may purchase an extended warranty.
Warrant [Member]
Product Information [Line Items]
Deferred revenue	$ 0.1
Revenue Benchmark [Member]
Product Information [Line Items]
Extended product warranty description	Deferred revenue represents the purchase of extended warranties by the Company’s customers. The Company recognizes revenue from an extended warranty on the straight-line method over the life of the extended warranty, which is typically 12 to 15 months
Standard product warranty description	standard 12 to 18-month warranty.

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 28, 2024 USD ($)	Sep. 28, 2024 USD ($)
Income Tax Disclosure [Abstract]
Current Income Tax Expense (Benefit)	$ 0.1	$ 0.1
Operating Loss Carryforwards	122.7	$ 122.7
[custom:OperatingLossCarryforwardsExpiringDate]		expiring 2024 through 2038
[custom:OperatingLossCarryforwardsUnlimited-0]	$ 107.8	$ 107.8

SCHEDULE OF CONTRACT WITH CUSTO

SCHEDULE OF CONTRACT WITH CUSTOMER, ASSET AND LIABILITY (Details) - USD ($)	9 Months Ended
	Sep. 28, 2024	Dec. 30, 2023
Contract Assets And Liabilities
Contract assets and unbilled receivables-current	$ 8,274,538	$ 3,409,809
Change in contract assets and unbilled receivables-current	$ 4,864,729
Percentage of contract assets and unbilled receivables-current	143%
Contract liabilities and billings in excess of revenue earned	$ (268,468)	(916,826)
Change in contract liabilities and billings in excess of revenue earned	$ 648,358
Percentage of contract liabilities and billings in excess of revenue earned	(71.00%)
Contract liabilities-noncurrent		(23,198)
Change in contract liabilities-noncurrent	$ 23,198
Percentage of contract liabilities-noncurrent	(100.00%)
Net contract assets	$ 8,006,070	$ 2,469,785
Change in net contract assets	$ 5,536,285
Percentage of net contract assets	224%

SCHEDULE OF SATISFACTION OF PER

SCHEDULE OF SATISFACTION OF PERFORMANCE OBLIGATION (Details)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Transferred at Point in Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	11%	24%	16%	27%
Transferred over Time [Member]
Disaggregation of Revenue [Line Items]
Performance obligation percentage	89%	76%	84%	73%

CONTRACT ASSETS AND LIABILITI_3

CONTRACT ASSETS AND LIABILITIES (Details Narrative) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Contract Assets And Liabilities
Net contract assets	$ 5.5		$ 5.5
Contract with customer, liability, revenue recognized	0.1	$ 0.1	0.9	$ 0.7
Revenue, remaining performance obligation, amount	$ 25.4		$ 25.4

SCHEDULE OF LEASE EXPENSE (Deta

SCHEDULE OF LEASE EXPENSE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Leases
Operating lease cost	$ 218,348	$ 216,119	$ 651,718	$ 648,545

SCHEDULE OF FUTURE LEASE PAYMEN

SCHEDULE OF FUTURE LEASE PAYMENT UNDER NON-CANCELLABLE LEASE (Details)	Sep. 28, 2024 USD ($)
Leases
2024 (excluding the nine months ended September 28, 2024)	$ 212,013
2025	766,014
2026	732,610
2027	669,255
2028	201,333
Total future lease payments	2,581,225
Less imputed interest	(293,289)
Total	$ 2,287,936

SCHEDULE OF OPERATING LEASE PAY

SCHEDULE OF OPERATING LEASE PAYMENTS RECOGNIZED IN CONSOLIDATED BALANCE SHEETS (Details) - USD ($)	Sep. 28, 2024	Dec. 30, 2023
Leases
Operating lease liabilities–current	$ 653,546	$ 651,503
Operating lease liabilities–noncurrent	1,634,390	$ 1,832,982
Total	$ 2,287,936

SCHEDULE OF SUPPLEMENTAL INFORM

SCHEDULE OF SUPPLEMENTAL INFORMATION RELATED TO LEASES (Details) - USD ($)	9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023
Leases
Cash paid for amounts included in the measurement of operating lease liabilities	$ 649,276	$ 741,757
Weighted Average Discount Rate - Operating Leases	6.80%	6.06%
Weighted Average Remaining Lease Term-Operating Leases (in years)	3 years 4 months 17 days	4 years 1 month 9 days

SCHEDULE OF LONG-LIVED ASSETS B

SCHEDULE OF LONG-LIVED ASSETS BY GEOGRAPHIC AREAS (Details) - USD ($) $ in Thousands	Sep. 28, 2024	Dec. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Long lived assets	$ 4,322	$ 4,668
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Long lived assets	4,199	4,424
UNITED KINGDOM
Revenues from External Customers and Long-Lived Assets [Line Items]
Long lived assets	$ 123	$ 244

SCHEDULE SEGMENT INFORMATION BY

SCHEDULE SEGMENT INFORMATION BY REVENUE TYPE (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 13,319,608	$ 10,598,497	$ 35,688,672	$ 31,816,544
Percentage of total revenue	100%	100%	100%	100%
UNITED STATES
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 12,612,000	$ 9,879,000	$ 33,352,000	$ 27,788,000
Percentage of total revenue	95%	94%	93%	88%
Other Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues			$ 5,000	$ 5,000
Percentage of total revenue
Americas [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 12,612,000	$ 9,879,000	$ 33,357,000	$ 27,793,000
Percentage of total revenue	95%	94%	93%	88%
Asia Pacific [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 382,000	$ 363,000	$ 1,632,000	$ 2,956,000
Percentage of total revenue	3%	3%	5%	9%
Europe [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total Revenues	$ 326,000	$ 356,000	$ 700,000	$ 1,068,000
Percentage of total revenue	2%	3%	2%	3%

SCHEDULE OF SEGMENT REPORTING I

SCHEDULE OF SEGMENT REPORTING INFORMATION, BY SEGMENT (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023
Revenue from External Customer [Line Items]
Total Revenues	$ 13,319,608	$ 10,598,497	$ 35,688,672	$ 31,816,544
Defense [Member]
Revenue from External Customer [Line Items]
Total Revenues	10,434,000	4,996,000	29,095,000	16,482,000
Industrial [Member]
Revenue from External Customer [Line Items]
Total Revenues	489,000	310,000	1,883,000	2,118,000
Consumer [Member]
Revenue from External Customer [Line Items]
Total Revenues		200,000	25,000	573,000
Research and Development [Member]
Revenue from External Customer [Line Items]
Total Revenues	2,268,000	4,956,000	4,338,000	11,737,000
License and Royalties [Member]
Revenue from External Customer [Line Items]
Total Revenues	$ 129,000	$ 136,000	$ 348,000	$ 907,000

LITIGATION (Details Narrative)

LITIGATION (Details Narrative) - USD ($) $ in Millions			9 Months Ended
	May 22, 2024	Apr. 22, 2024	Sep. 28, 2024
Commitments and Contingencies Disclosure [Abstract]
Damages		On Monday, April 22, 2024, after a four week trial, a jury verdict was entered finding for BlueRadios and awarding approximately $5.1 million in damages as well as recommending $19.7 million in disgorgement and exemplary damages. While no final judgment has been issued by the Court, the Court will take that recommendation under advisement and will rule in its final judgment on the final amount after post-trial briefing.
Prejudgement interest	$ 10
Fee and costs	$ 10
Damages value			$ 5.1
Exemplary damages value			$ 19.7

SCHEDULE OF TRANSACTIONS WITH R

SCHEDULE OF TRANSACTIONS WITH RELATED PARTIES (Details) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 28, 2024	Sep. 30, 2023	Sep. 28, 2024	Sep. 30, 2023	Dec. 30, 2023
Related Party Transaction [Line Items]
Revenue with related parties	$ 205,984	$ 485,338	$ 647,617	$ 1,757,739
Purchases with related parties	6,650	208,933	193,305	416,988
Receivables with related parties	230,105		230,105		$ 144,915
Payables with related parties					97,600
RealWear, Inc. [Member]
Related Party Transaction [Line Items]
Revenue with related parties	94,854	135,918	311,994	905,564
Purchases with related parties			10,550
Receivables with related parties	94,854		94,854		94,902
Payables with related parties
HMDmd, Inc. [Member]
Related Party Transaction [Line Items]
Revenue with related parties	76,918	349,420	299,177	852,175
Purchases with related parties
Receivables with related parties	101,922		101,922		15,000
Payables with related parties
Vuzix Corp [Member]
Related Party Transaction [Line Items]
Revenue with related parties
Purchases with related parties			11,905
Solos Technology [Member]
Related Party Transaction [Line Items]
Revenue with related parties	33,288		33,288
Purchases with related parties
Receivables with related parties	33,288		33,288
Payables with related parties
Lightning Silicon Techonology Inc [Member]
Related Party Transaction [Line Items]
Revenue with related parties	924		3,158
Purchases with related parties	6,650	$ 208,933	170,850	$ 416,988
Receivables with related parties	41		41		35,013
Payables with related parties					$ 97,600

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	Jan. 05, 2023	Sep. 28, 2024	Dec. 30, 2023
Investments		$ 5,200,000
Lightning Silicon Technology Inc [Member]
Issuance of shares	18,000,000
Ownership percentage	20%
Investments		$ 0	$ 0